We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Staffing Getting Easier Despite High-Profile Self-Recusal
FDA Panel Staffing Getting Easier Despite High-Profile Self-Recusal
While the recent self-recusal of FDA advisory committee member Andrew Brill has drawn attention to conflict-of-interest issues, the agency says it is having better luck filling the gaps on its advisory panels than in years past.